Health
Moderna skyrockets 11% after receiving additional $472 million of funding, starting Phase 3 trial of COVID-19 vaccine – Business Insider Australia
- Moderna on Sunday announced it received a commitment of up to $US472 million in additional funding from its contract with the Biomedical Advanced Research and Development Authority.
- The company on Monday announced that the Phase 3 trial for its COVID-19 vaccine had started dosing participants.
- Shares of Moderna surged as much as 11% in premarket trading Monday
- Watch Moderna trade live on Markets Insider.
- Read more on Business Insider.
Shares of …
Continue Reading
-
Noosa News18 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General19 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General23 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says
-
General10 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat